Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Does a Customized Intubation Facility Reduce Incidence of Difficulty (Person-OTI)

9 de junio de 2026 actualizado por: Hopital Foch

Does a Customized Intubation Facility Reduce Incidence of Difficulty: Randomized Multicenter Trial?

The idea of this study is to demonstrate that the position of the head at a comfort height spontaneously expressed by the patient, between Jackson's amended position or Ramp position, significantly improves the quality of the intubation gesture. This patient position can be easily achieved by placing a compressed air mattress under the patient's trunk - AirPal RAMP ™ mattress.

Thus the investigators can assume that the appropriate positioning and use of a video laryngoscope (McGrathR Mac) places the patient in the best anatomical configuration to breathe and, indirectly to facilitate control of the airways, especially for those with a risk of difficult airway management.

Descripción general del estudio

Descripción detallada

  1. Position for orotracheal intubation The period preceding the administration of anesthetic agents is essential to ensure a satisfactory oxygen supply (pre-oxygenation). Then, once loss of consciousness is achieved, an interface (oral intubation probe) is put in place to allow mechanical ventilation during the procedure. This phase can be marked by a more or less expected difficulty depending on the risk factors presented by the patient. Thus an Arne score> 11 is predictive of a potential difficulty which may lead to an alternative technique being proposed. Simple techniques also exist in the patient setup to reduce the incidence of difficulties. Among them, the placement of a cushion under the head with a slight extension of the head of 20 ° (Jackson's amended position) is recommended because it allows to obtain the alignment of the posterior pharyngeal and glottic spaces. This patient position can be easily achieved by placing a compressed air mattress under the patient's trunk - AirPal RAMP ™ mattress.

    This optimization of the position according to the patient, between Jackson's amended position or Ramp position, opens up the prospect of defining an optimal position personalized to each patient. Thus, it can be assumed that the appropriate positioning places the patient in the best anatomical configuration for breathing and, indirectly, to facilitate control of the airways.

  2. Video laryngoscope The use of a video laryngoscope (McGrathR Mac) is becoming widespread in anesthesia, especially for the management of patients at risk of difficult airway management. This device by the video support at the end of the blade provides a better visualization of the glottic orifice.
  3. The hypothesis of this research The idea of this study is to demonstrate that the position of the head at a height of comfort spontaneously expressed by the patient significantly improves the quality of the intubation procedure.

Tipo de estudio

Intervencionista

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Suresnes, Francia, 92150
        • Morgan LE GUEN, PhD

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Men or women over 18 and under 80;
  • Must undergo general anesthesia with oral intubation using a standard intubation probe;
  • Can be contacted directly by telephone if they are patients treated in outpatient surgery;
  • Having signed a consent form;
  • Being affiliated to a Health Insurance scheme.

Exclusion Criteria:

  • pregnant or breastfeeding patients;
  • patients with a predicted difficulty in mask ventilation or intubation according to the assessment of the doctor who performs the clinical examination prior to inclusion (Arne score ≥ 11) or the one who takes care of the patient in the block operative;
  • patients for whom the surgery requires the placement of a double-lumen tube;
  • patients requiring rapid sequence induction;
  • patients for whom induction cannot be carried out by the sufentanil, propofol, atracurium or rocuronium sequence.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Custom
patient with installation on an infused airbag until a comfortable position is reached
patient with personalized installation until a comfortable position is reached
Sin intervención: Control
Jackson's amended position with placement of a 6 cm high cushion under the patient's head

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
the impact of a custom installation versus a conventional Jackson amended installation with a 6-centimeter cushion under the patient's head to facilitate orotracheal intubation
Periodo de tiempo: 1 day
the proportion of orotracheal intubations for which third party assistance is required
1 day

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Assessment of the effect of patient positioning on the quality of exposure during intubation
Periodo de tiempo: 1 day
  • the duration of the intubation;
  • the quality of visualization of the glottis;
  • failure of intubation defined by reexposure, by esophageal intubation;
  • the calculation of the Intubation Difficulty Scale (or IDS)
1 day
Determination of the most frequent complementary resettlement actions
Periodo de tiempo: 1 day
  • the ideal position chosen by the patient (and measured) before the start of the procedure;
  • the patient's position (measured) when the intubation is successful. The intubation time will be correlated with these measurements and the angles that will be deduced from them;
  • additional techniques used at the time of intubation.
1 day
Assessment of the quality of manual ventilation before intubation (peroxygenation)
Periodo de tiempo: 1 day
  • the use of a Guédel cannula;
  • the number of hands required for ventilation;
  • the percentage of leakage;
  • minimal SpO2;
  • maximum ETCO2.
1 day
Assessment of the frequency and severity of complications of intubation
Periodo de tiempo: 2 days
The complications of intubation was defined by the pharyngeal pain the day after surgery, dysphonia, an irritative cough reported by the patient and atelectasis.
2 days
Assessment of patient comfort and the doctor's opinion on the technique
Periodo de tiempo: 1 day
The doctor's opinion on the technique was defined by the regard to pre-oxygenation, peroxygenation, and intubation.
1 day
Safety assessment of the technique
Periodo de tiempo: 1 day
Safety was evaluated by the occurrence of a fall of the head, occurrence of a fall of the patient, accidental extubation, the incidence of arterial oxygen desaturation, the lowest arterial oxygen saturation and the perception of difficulty in intubation.
1 day

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

5 de enero de 2022

Finalización primaria (Actual)

5 de enero de 2024

Finalización del estudio (Actual)

12 de enero de 2024

Fechas de registro del estudio

Enviado por primera vez

6 de agosto de 2021

Primero enviado que cumplió con los criterios de control de calidad

9 de junio de 2026

Publicado por primera vez (Actual)

15 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

15 de junio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

9 de junio de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 2020_0030

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir